The purpose of this requirement is to provide outpatient hansen's disease services, which includes diagnosis, screening, outpatient treatment, case management, and follow-up care in healthcare…
Active Definitive Contract Awarded Last action
- Contract number
- 75R60123C00007
- Awardee
-
New York Health And Hospitals Corporation UEI XBZSNT3JJRW9
- Awarding agency
-
National Hansens Disease Program Clinical Research Center
Health Resources and Services Administration, Department of Health and Human Services
- Obligated
- $1,267,925
Award facts
- Opportunity
-
- National Hansen’s Disease Program Ambulatory Care Contracts Pre-Solicitation · 75R60123R00001 · Posted Feb 1, 2023
- Contract value 69% obligated
-
- $1,267,925.00 Current, with exercised options
- $1,844,840.00 Potential, with all options
- Completion date 62% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 621999 All Other Miscellaneous Ambulatory Health Care Services
- PSC
- Q201 Medical- Managed Healthcare
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10016, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $373,484 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $365,441 | |
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $357,632 | |
| Exercise an Option | $0 | |
| Original award | $171,368 |
About this award
The National Hansen's Disease Program Clinical Research Center awarded a $1.844 million firm fixed price definitive contract to New York Health And Hospitals Corporation (doing business as Bellevue Hospital Center) for outpatient Hansen's disease services on September 28, 2023, with no set-aside.
The contract provides diagnosis, screening, outpatient treatment, case management, and follow-up care for Hansen's disease in healthcare settings throughout the United States, with place of performance in New York, NY. The originating solicitation, posted February 1, 2023, called for multiple firm fixed price contracts to continue mandated ambulatory care services historically provided through U.S. Public Health Service hospitals. The base period runs six months with four option periods of twelve months each, extending through the ultimate completion date of September 27, 2028. NAICS code 621999 (other ambulatory health care services) applies.
Description
The purpose of this requirement is to provide outpatient hansen's disease services, which includes diagnosis, screening, outpatient treatment, case management, and follow-up care in healthcare settings located throughout the united states.
Quick answers
Who was awarded contract 75R60123C00007?
75R60123C00007 was awarded to New York Health And Hospitals Corporation by National Hansens Disease Program Clinical Research Center (Health Resources and Services Administration) on September 28, 2023.
How much is contract 75R60123C00007 worth?
The government has obligated $1,267,925 on 75R60123C00007. Its potential value, with all options, is $1,844,840.
Was contract 75R60123C00007 competed?
The extent of competition for 75R60123C00007 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award